Market Overview - On January 26, A-shares saw a collective decline with the Shanghai Composite Index down 0.09% at 4132 points, the Shenzhen Component down 0.85%, and the ChiNext Index down 0.91% [1][2] - The total market turnover reached 3.28 trillion yuan, an increase of 162.5 billion yuan compared to the previous trading day, with over 3700 stocks declining [1] Sector Performance - The commercial aerospace and satellite internet sectors experienced significant pullbacks, with stocks like China Satellite and Aerospace Development hitting the daily limit down [2][4] - The military industry sector also fell, with stocks such as Chaojie Co. dropping over 10% [2] - Conversely, international gold and silver prices surged to new highs, leading to a rally in precious metals and non-ferrous metals sectors, with stocks like Xiaocheng Technology and Western Gold hitting the daily limit up [2][10] - The outbreak of the Nipah virus in India caused a collective rise in the biopharmaceutical and vaccine sectors [2][14] Notable Stock Movements - In the military equipment sector, Aerospace Hanyu fell over 11%, while China Satellite and Aerospace Technology hit the daily limit down [4] - In the semiconductor equipment sector, stocks like Su Dawei and Wo Ge Optoelectronics saw significant declines, with some stocks dropping over 11% [5][8] - The humanoid robot sector also faced declines, with stocks like Haoshi Machinery and Lixing Co. dropping over 13% [6][9] - The biopharmaceutical sector saw notable gains, with stocks like Hualan Vaccine and Jindike hitting the daily limit up due to the Nipah virus outbreak [14] Investment Insights - The coal sector showed strength, with China Shenhua rising over 4% and other coal stocks following suit [18] - The insurance sector also performed well, with stocks like New China Life and China Pacific Insurance seeing gains [15][16] - The market outlook suggests a focus on sectors with performance verification, particularly in price increase chains, high-end manufacturing, and AI-related industries [19]
A股收评:创业板跌近1%,贵金属、生物疫苗板块逆势爆发